Methods and compositions for the sustained release of chromium

A method for administering chromium over a period of time, comprising providing a first chromium complex and a second chromium complex, wherein said first chromium complex is absorbed more quickly than the second chromium complex and said second chromium complex is absorbed more slowly than said first chromium complex.

A method for reducing pre-prandial and post-prandial glucose levels, comprising:

• co-administering a therapeutically effective amount to a subject of a first chromium complex and a second chromium complex, wherein said first chromium complex is hydrophilic and wherein said second chromium complex is lipophilic.

A method for reducing hyperglycemia or stabilizing serum glucose levels in a subject in need thereof, comprising:

• co-administering a synergistically effective amount to a subject of a first chromium complex and a second chromium complex to said subject, wherein said first chromium complex is hydrophilic and wherein said second chromium complex is lipophilic.

A method for improving insulin sensitivity in a subject in need thereof, comprising:

• co-administering a therapeutically effective amount to a subject of a first chromium complex and a second chromium complex to said subject, wherein said first chromium complex is hydrophilic and wherein said second chromium complex is lipophilic.

A method for reducing free fatty acid levels in a subject in need thereof, comprising:

• co-administering to a subject a therapeutically effective amount of a first chromium complex and a second chromium complex to said subject.

A method for treating dyslipidemia in a subject in need thereof, comprising:

• co-administering to a subject a therapeutically effective amount of a first chromium complex and a second chromium complex to said subject.

A method for reducing the risk of developing cardiometabolic syndrome in a subject in need thereof, comprising:

• co-administering to a subject a therapeutically effective amount of a composition first chromium complex and a second chromium complex to said subject.

A method for maintaining healthy serum glucose levels in a subject, comprising:

• co-administering to a subject a therapeutically effective amount of a composition first chromium complex and a second chromium complex to said subject.

A method for maintaining healthy cholesterol levels in a subject, comprising:

• co-administering to a subject a therapeutically effective amount of a composition first chromium complex and a second chromium complex to said subject.

A method of maintaining a healthy level of lean body mass in a subject, comprising:

• co-administering to a subject a therapeutically effective amount of a composition of a first chromium complex and a second chromium complex to said subject.

A method of preventing hyperglycemia in a subject, comprising:

• co-administering to a subject a therapeutically effective amount of a composition of a first chromium complex and a second chromium complex to said subject.

An improved composition for lowering serum glucose levels, comprising a synergistically effective amount of chromium histidinate and chromium picolinate, wherein said synergistically effective amount of chromium histidinate and said chromium picolinate have a greater than additive effect in lowering serum glucose levels.

An improved composition for improving insulin sensitivity, comprising a synergistically effective amount of chromium histidinate and chromium picolinate, wherein said synergistically effective amount of chromium histidinate and said chromium picolinate have a greater than additive effect in improving insulin sensitivity.

An improved composition for treating dyslipidemia, comprising a synergistically effective amount of chromium histidinate and chromium picolinate, wherein said synergistically effective amount of chromium histidinate and said chromium picolinate have a greater than additive effect in treating dyslipidemia.

An improved composition for increasing lean muscle mass, comprising a synergistically effective amount of chromium histidinate and chromium picolinate, wherein said synergistically effective amount of chromium histidinate and said chromium picolinate have a greater than additive effect in increasing lean muscle mass.